Evidence map›Paper›PMID 40497845›Full record

ArticleNanomaterials (Basel, Switzerland)2025

Selective Photothermal Therapy Using Antioxidant Nanoparticles Encapsulating Novel Near-Infrared-Absorbing Platinum(II) Complexes.

Ryota Sawamura, Hiromi Kurokawa, Atsushi Taninaka, Takuto Toriumi, Yukio Nagasaki, Hidemi Shigekawa, Hirofumi Matsui, Nobuhiko Iki

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryota SawamuraGraduate School of Environmental Studies, Tohoku University, 6-6-07 Aramaki-Aoba, Aoba-ku, Sendai 980-8579, Miyagi, Japan.ORCID 0000-0002-8799-5869
Hiromi KurokawaPhycochemy Corporation, X/S Worksite, 4-19-1 Midorigahara, Tsukuba 305-0035, Ibaraki, Japan.
Atsushi TaninakaInstitute of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8573, Ibaraki, Japan.
Takuto ToriumiFaculty of Materials for Energy, Shimane University, 1060 Nishikawatsu-cho, Matsue 690-8504, Shimane, Japan.
Yukio NagasakiGraduate School of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.ORCID 0000-0001-7975-6510
Hidemi ShigekawaInstitute of Pure and Applied Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8573, Ibaraki, Japan.
Hirofumi MatsuiFaculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.ORCID 0000-0002-7659-5093
Nobuhiko IkiGraduate School of Environmental Studies, Tohoku University, 6-6-07 Aramaki-Aoba, Aoba-ku, Sendai 980-8579, Miyagi, Japan.ORCID 0000-0003-4698-4992

Funding

Japan Society for the Promotion of Science 19H05458, 22H02101, and 24K17702
6 · The paper itself

Abstract

Photothermal therapy (PTT) is a promising approach for cancer treatment that has minimal side effects. It locally heats tumors using agents that convert near-infrared (NIR) light energy into heat. We previously reported that the NIR-absorbing hydrophobic diradical-platinum(II) complex PtL

Indexed as

antioxidant nanoparticlescancer cell-specificitydiradical-platinum complexesnear-infrared absorptionphotothermal therapy

Identifiers

PMID40497845
PMCPMC12158251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.